Get the Stockscreener App
37.19
3.05%
1.10
Surmodics Inc stock is traded at $37.19, with a volume of 966.85K.
It is up +3.05% in the last 24 hours and up +16.56% over the past month.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
See More
Previous Close:
$36.09
Open:
$36.25
24h Volume:
966.85K
Relative Volume:
6.51
Market Cap:
$531.73M
Revenue:
$138.20M
Net Income/Loss:
$5.52M
P/E Ratio:
97.87
EPS:
0.38
Net Cash Flow:
$9.86M
1W Performance:
-0.72%
1M Performance:
+16.56%
6M Performance:
+6.71%
1Y Performance:
-6.93%
1-Day Range:
$35.28
$37.77
1-Week Range:
$34.99
$38.42
52-Week Range:
$26.00
$40.38
Surmodics Inc Stock (SRDX) Company Profile
Name
Surmodics Inc
Sector
Industry
Phone
(952) 500-7000
Address
9924 W 74TH ST, EDEN PRAIRIE, MN
Compare SRDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
37.19 | 527.44M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-25 | Upgrade | Lake Street | Hold → Buy |
| Jun-13-23 | Upgrade | Needham | Hold → Buy |
| Feb-13-23 | Downgrade | Needham | Buy → Hold |
| Jul-23-20 | Upgrade | Needham | Hold → Buy |
| Dec-11-19 | Downgrade | Needham | Buy → Hold |
| Nov-01-19 | Downgrade | Lake Street | Buy → Hold |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Lake Street | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Feb-21-19 | Reiterated | Needham | Buy |
| May-16-18 | Reiterated | Needham | Buy |
| Mar-01-18 | Upgrade | Sidoti | Neutral → Buy |
| Feb-28-18 | Reiterated | Lake Street | Buy |
| Feb-28-18 | Initiated | Needham | Buy |
| Jul-14-17 | Initiated | Lake Street | Buy |
| Nov-21-16 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Oct-06-16 | Downgrade | Sidoti | Buy → Neutral |
| May-03-16 | Reiterated | Barrington Research | Outperform |
| Aug-06-15 | Reiterated | Barrington Research | Outperform |
| Mar-27-15 | Initiated | Dougherty & Company | Buy |
| Feb-25-14 | Initiated | Laidlaw | Buy |
| Aug-01-13 | Upgrade | Feltl & Co. | Buy → Strong Buy |
| Nov-12-12 | Reiterated | Barrington Research | Outperform |
View All
Surmodics Inc Stock (SRDX) Latest News
What Fibonacci levels say about Surmodics Inc. rebound2025 Support & Resistance & Weekly Chart Analysis and Trade Guides - Newser
Surmodics Inc. Recovery Likely Here’s What Data ShowsQuarterly Earnings Report & Community Consensus Picks - classian.co.kr
Is Surmodics Inc. in a long term uptrendPortfolio Return Summary & Risk Adjusted Buy/Sell Alerts - thegnnews.com
Using flow based indicators on Surmodics Inc.Market Growth Summary & Real-Time Volume Trigger Notifications - Newser
How to forecast Surmodics Inc. trends using time series2025 Performance Recap & Weekly High Momentum Picks - Newser
Will Surmodics Inc. see short term momentumTreasury Yields & Stepwise Trade Signal Guides - Newser
How high can Surmodics Inc. stock go2025 Top Decliners & Reliable Price Breakout Alerts - Newser
Is Surmodics Inc. stock reversal real or fakeIPO Watch & Reliable Breakout Forecasts - Newser
What data driven models say about Surmodics Inc.’s futureBuy Signal & Community Verified Watchlist Alerts - Newser
Visualizing Surmodics Inc. stock with heatmapsQuarterly Risk Review & Low Drawdown Trading Strategies - Newser
Intraday pattern recognizer results for Surmodics Inc.2025 Top Gainers & Fast Gaining Stock Reports - Newser
Will Surmodics Inc. rebound enough to break evenJuly 2025 Big Picture & Weekly Market Pulse Updates - Newser
Using fundamentals and technicals on Surmodics Inc.Portfolio Growth Summary & Weekly Top Gainers Alerts - Newser
Using data filters to optimize entry into Surmodics Inc.2025 Geopolitical Influence & AI Driven Price Predictions - Newser
Understanding Surmodics Inc.’s price movementExit Point & Daily Technical Forecast Reports - Newser
Tools to assess Surmodics Inc.’s risk profileJuly 2025 Pullbacks & Stock Timing and Entry Methods - Newser
Will Surmodics Inc. price bounce be sustainableLayoff News & Daily Growth Stock Investment Tips - Newser
Is this a good reentry point in Surmodics Inc.Insider Selling & Technical Pattern Based Buy Signals - Newser
Does Surmodics Inc. qualify in momentum factor screeningMarket Trend Review & Risk Managed Investment Strategies - Newser
Detecting price anomalies in Surmodics Inc. with AIJuly 2025 Trade Ideas & AI Powered Market Entry Ideas - Newser
Is Surmodics Inc. trending in predictive chart modelsWeekly Trend Summary & Risk Controlled Daily Trade Plans - Newser
Is a relief rally coming for Surmodics Inc. holders2025 Performance Recap & AI Forecast Swing Trade Picks - Newser
What makes Surmodics Inc. stock price move sharplyShare Buyback & Long-Term Growth Plans - thegnnews.com
Does Surmodics Inc. show high probability of reboundWeekly Trend Report & Free Growth Oriented Trading Recommendations - Newser
Why Surmodics Inc. stock attracts strong analyst attentionQuarterly Market Summary & High Conviction Buy Zone Alerts - 선데이타임즈
How Efficient Is Surmodics Inc. at Controlling Operating CostsGap Up & Safe Capital Allocation Plans - Newser
Options Data Show Bullish Bias in Surmodics Inc.2025 Year in Review & Verified Momentum Watchlists - classian.co.kr
Surmodics Reports Mixed Financial Results, Highlighting Profit Growth and Sales Challenges in June 2025 - MarketsMojo
Barrington Research Forecasts Lower Earnings for Surmodics - Defense World
Surmodics FY2025 EPS Estimate Raised by Barrington Research - Defense World
Are Bears Losing Grip on Surmodics Inc.Trade Exit Summary & Long-Term Growth Stock Strategies - beatles.ru
Using Bollinger Bands to evaluate Surmodics Inc.2025 Price Action Summary & Reliable Entry Point Trade Alerts - Newser
Is Surmodics Inc. stock a growth or value playROI Focused Watchlist with Trade Confidence - Newser
FTC Skeptical Of 'Partial' Sale For GTCR Merger Fix - Law360
SRDX Stock Up Following Q3 Earnings Beat, Gross Margin Contracts - TradingView
GTCR-Surmodics divestiture to be evaluated by FTC by Aug. 15, US court told - MLex
Surmodics (NASDAQ:SRDX) Shares Up 8.7% Following Strong Earnings - Defense World
What is the target price for Surmodics Inc. stockPrice Volume Breakout Screener - newsyoung.net
Analyzing drawdowns of Surmodics Inc. with statistical toolsSecure Asset Flow and Trend Pattern Analysis - Newser
Is Surmodics Inc. exposed to political riskQuality Dividend Stock Finder - newsyoung.net
Surmodics (SRDX) Maintains Market Perform Rating by Barrington Research - AInvest
SurModics Maintains Hold Rating Amid Mixed Financial Performance and Ongoing Litigation - AInvest
SurModics: Hold Rating Amid Mixed Financial Performance and Legal Uncertainties - TipRanks
Surmodics revenue down 3% to USD 29.6M in Q3 2025 - Medical Buyer
SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - NewsBreak: Local News & Alerts
Surmodics 2025 Q3 Earnings Loss Narrows 29.6% - AInvest
SurModics' Strong Financials Offset by Acquisition Uncertainty - AInvest
SurModics: Fiscal Q3 Earnings Snapshot - Connecticut Post
Surmodics Lifts Guidance Despite Dips In Device Revenue - Finimize
GTCR, Surmodics file opposition to US FTC's motion for preliminary injunction - MLex
UPDATE: FTC request for GTCR/Surmodics divestiture docs denied - Global Competition Review
Surmodics Inc Stock (SRDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Surmodics Inc Stock (SRDX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DANTZKER DAVID | Director |
Feb 13 '25 |
Option Exercise |
27.30 |
5,275 |
144,008 |
44,399 |
| BEDOYA JOSE H | Director |
Feb 14 '25 |
Option Exercise |
27.30 |
5,275 |
144,008 |
34,232 |
| KNIGHT SUSAN E | Director |
Jan 24 '25 |
Option Exercise |
27.30 |
7,358 |
200,873 |
42,506 |
| Arens Timothy J. | Chief Financial Officer |
Nov 26 '24 |
Sale |
39.44 |
7,009 |
276,453 |
70,350 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):